MC-1-F2

N/A

Report date: 2023/10/17 14:28:36
NME

Base Information

Drug NameMC-1-F2
Drug Alias NameMC-1-F2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionForkhead box protein C2 inhibitors
TargetsForkhead box protein C2
Therapy Area/IndicationsProstatic Neoplasms, Castration-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University of Texas at Dallas
China Registration ClassN/A

Develop Information

Active CompaniesThe University of Texas at Dallas
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A